Sign in
4/A

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-08-000002

Interim CEO bought 5,000 shares at $0.89 ($4,450)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Babcock Dwight William Interim CEO 2008-05-19 Purchase +5,000 $0.89 $4,450 63,307 D
Derivatives
Babcock Dwight William Interim CEO 2008-05-13 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Open-market purchases · 5,000 sh · avg $0.89 · $4,450
Loading xslF345X02/primary_doc.xml…